Structure, Immunogenicity, and Protectivity Relationship for the 1585 Malarial Peptide and Its Substitution Analogues.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Angewandte Chemie

• Publication date

  2001-12-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/1521-3773(20011217)40:24<4654::AID-ANIE4654>3.0.CO;2-FPMID 12404375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, Biological, and Immunological Properties of Cyclic Peptides from Plasmodium Falciparum Merozoite Surface Protein-1.

  2001cited by this paper
• Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells

  2000cited by this paper
• Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development.

  2000cited by this paper
• The immunology of malaria infection.

  2000cited by this paper
• Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling.

  2000cited by this paper
• Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.

  2000cited by this paper
• Malaria vaccine development: current status.

  1998cited by this paper
• Research toward vaccines against malaria

  1998cited by this paper
• Identification of Plasmodium falciparum MSP‐1 peptides able to bind to human red blood cells

  1996cited by this paper
• Malaria pathogenesis.

  1994cited by this paper
• What is the function of MSP-I on the malaria merozoite?

  1994cited by this paper
• Importance of environment in determining secondary structure in proteins.

  1994cited by this paper
• Importance of environment in determining secondary structure in proteins.

  1994cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Malaria-a neglected disease?

  1992cited by this paper
• Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum.

  1990cited by this paper
• NMR of proteins and nucleic acids

  1988cited by this paper
• General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

  1985cited by this paper

• SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World’s Population

  2022cites this paper
• From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax

  2020cites this paper
• The molecular basis for peptide-based antimalarial vaccine development targeting erythrocyte invasion by P. falciparum.

  2020cites this paper
• Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

  2019cites this paper
• A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria

  2017cites this paper
• Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective

  2017cites this paper
• Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A*0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein.

  2016cites this paper
• Immune protection-inducing protein structures (IMPIPS) against malaria: the weapons needed for beating Odysseus.

  2015cites this paper
• Recent advances in the development of a chemically synthesised anti-malarial vaccine

  2015influential citation
• 3D structure determination of STARP peptides implicated in P. falciparum invasion of hepatic cells.

  2014cites this paper
• Using the PfEMP1 Head Structure Binding Motif to Deal a Blow at Severe Malaria

  2014cites this paper
• Gauche(+) side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine.

  2014cites this paper
• Steric-electronic effects in malarial peptides inducing sterile immunity.

  2012cites this paper
• Phi (Φ) and psi (Ψ) angles involved in malarial peptide bonds determine sterile protective immunity.

  2012cites this paper
• Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development.

  2011cites this paper
• VACCINE FORMULATION: ADSORPTION OF Plasmodium falciparum MSP-1 PEPTIDE 1585 ON ALUMINIUM HYDROXIDE

  2011cites this paper
• Peptides and Glycopeptides

  2011cites this paper
• Atomic fidelity of subunit-based chemically-synthesized antimalarial vaccine components.

  2010cites this paper
• Development of Designed Site-Directed Pseudopeptide-Peptido-Mimetic Immunogens as Novel Minimal Subunit-Vaccine Candidates for Malaria

  2010cites this paper
• Sequences of the Plasmodium falciparum cytoadherence-linked asexual protein 9 implicated in malaria parasite invasion to erythrocytes.

  2010cites this paper
• High affinity interactions between red blood cell receptors and synthetic Plasmodium thrombospondin-related apical merozoite protein (PTRAMP) peptides.

  2008cites this paper
• Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.

  2008cites this paper
• Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine.

  2008cites this paper
• Identification of Plasmodium falciparum RhopH3 protein peptides that specifically bind to erythrocytes and inhibit merozoite invasion

  2008cites this paper
• Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines

  2008influential citation
• Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine.

  2008cites this paper
• A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development.

  2007cites this paper
• A rational strategy for a malarial vaccine development.

  2007cites this paper
• Structural modifications to a high-activity binding peptide located within the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeys

  2007cites this paper
• PEPTIDE SOLUBILITY, STRUCTURE AND CHARGE POSITION EFFECT ON ADSORPTION BY ALUMINIUM HYDROXIDE

  2006cites this paper
• Developmental Biology of Sporozoite-Host Interactions in Plasmodium falciparum Malaria: Implications for Vaccine Design

  2006cites this paper
• Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex.

  2006cites this paper
• Peptide Vaccines for Malaria

  2006cites this paper
• Plasmodium falciparum merozoite surface protein 6 (MSP-6) derived peptides bind erythrocytes and partially inhibit parasite invasion.

  2006cites this paper
• Fitting modified HRP-I peptide analogue 3D structure into HLA-DR molecules induces protection against Plasmodium falciparum malaria.

  2005cites this paper
• Elongating modified conserved peptides eliminates their immunogenicity and protective efficacy against P. falciparum malaria.

  2005cites this paper
• Identifying Plasmodium falciparum cytoadherence‐linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes

  2005cites this paper
• Protection against malaria induced by chirally modified Plasmodium falciparum's MSP-1 42 pseudopeptides.

  2005cites this paper
• Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions.

  2005cites this paper
• Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection.

  2005cites this paper
• P. falciparum pro-histoaspartic protease (proHAP) protein peptides bind specifically to erythrocytes and inhibit the invasion process in vitro

  2005cites this paper
• Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells

  2005cites this paper
• Mycobacterium tuberculosis Rv2536 protein implicated in specific binding to human cell lines

  2005cites this paper
• Changing ABRA protein peptide to fit into the HLA-DRbeta1*0301 molecule renders it protection-inducing.

  2004cites this paper
• Identification of Plasmodium falciparum reticulocyte binding protein RBP-2 homologue a and b (PfRBP-2-Ha and -Hb) sequences that specifically bind to erythrocytes.

  2004cites this paper
• MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion.

  2004cites this paper
• Modifying RESA protein peptide 6671 to fit into HLA-DRbeta1* pockets induces protection against malaria.

  2004cites this paper
• Induction and displacement of an helix in the 6725 SERA peptide analogue confers protection against P. falciparum malaria.

  2004cites this paper
• Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria.

  2004cites this paper
• Structural Modifications Enable Conserved Peptides to Fit into MHC Molecules thus Inducing Protection against Malaria

  2004cites this paper
• Mapping the anatomy of a Plasmodium falciparum MSP-1 epitope using pseudopeptide-induced mono- and polyclonal antibodies and CD and NMR conformation analysis.

  2004cites this paper
• Identifying Plasmodium falciparum EBA-175 homologue sequences that specifically bind to human erythrocytes.

  2004cites this paper
• Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum-derived rhoptry-associated protein 1 peptides.

  2004cites this paper
• Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes.

  2004cites this paper
• P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes.

  2003cites this paper
• 6746 SERA peptide analogues immunogenicity and protective efficacy against malaria is associated with short alpha helix formation: malaria protection associated with peptides alpha helix shortening.

  2003cites this paper
• Plasmodium falciparum EBA-140 kDa protein peptides that bind to human red blood cells.

  2003cites this paper
• MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6.

  2003cites this paper
• Plasmodium falciparum SERA protein peptide analogues having short helical regions induce protection against malaria.

  2003cites this paper
• Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP).

  2003cites this paper
• Plasmodium falciparum normocyte binding protein (PfNBP-1) peptides bind specifically to human erythrocytes.

  2003cites this paper
• Modified merozoite surface protein-1 peptides with short alpha helical regions are associated with inducing protection against malaria.

  2003cites this paper
• Alpha helix shortening in 1522 MSP‐1 conserved peptide analogs is associated with immunogenicity and protection against P. falciparum malaria

  2003cites this paper
• Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.

  2003cites this paper
• 6746 SERA peptide analogues immunogenicity and protective efficacy against malaria is associated with short α helix formation

  2003cites this paper
• Immunogenicity and Protectivity of Plasmodium falciparum EBA-175 Peptide and Its Analog Is Associated with α-Helical Region Shortening and Displacement

  2003cites this paper
• MSP-1 Malaria Pseudopeptide Analogs: Biological and Immunological Significance and Three-Dimensional Structure

  2003cites this paper
• Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes.

  2003cites this paper
• NMR structure of Plasmodium falciparum malaria peptide correlates with protective immunity.

  2002cites this paper
• Protection against experimental malaria associated with AMA‐1 peptide analogue structures

  2002cites this paper
• Protection against experimental P. falciparum malaria is associated with short AMA-1 peptide analogue α-helical structures

  2002cites this paper
• Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells

  2000cites this paper